K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S201, 2003
Cavalier E, Delanaye P, Carlisi A, Krzesinski JM, Chapelle JP: Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney Int 72: 370-372, 2007
Holmes DT, Levin A, Forer B, Rosenberg F: Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem 51: 915-917, 2005
Joly D, Drueke TB, Alberti C, Houillier P, Lawson-Body E, Martin KJ, Massart C, Moe SM, Monge M, Souberbielle JC: Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: A cross-sectional study. Am J Kidney Dis 51: 987-995, 2008
Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P: Inter-method variability in PTH measurement: Implication for the care of CKD patients. Kidney Int 70: 345-350, 2006
Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR: Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: The CHOICE study. Nephrol Dial Transplant 23: 1650-1658, 2008
Lehmann G, Stein G, Huller M, Schemer R, Ramakrishnan K, Goodman WG: Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 68: 1206-1214, 2005
Reichel H, Esser A, Roth HJ, Schmidt-Gayk H: Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18: 759-768, 2003
Cavalier E, Delanaye P, Carlisi A, Krzesinski JM, Chapelle JP: Analytical validation of the new version of the Liaison N-Tact PTH assay. Clin Chem Lab Med 45: 105-107, 2007
Chatterjee S, Lahiri P, Li H: Parametric bootstrap approximation to the distribution of EBLUP and related prediction intervals in linear mixed models. The Annals of Statistics 36: 1221-1245, 2008
De Gryze S, Langhans I, Vandebroek M: Using the correct intervals for prediction: A tutorial on tolerance intervals for ordinary least-squares regression. Chemom Intell Lab Syst 87: 147-154, 2007
International Organization for Standardization (ISO): ISO/CEI 17025: General requirements for the competence of testing and calibration laboratories, Geneva, 2005
International Organization for Standardization (ISO): ISO/CEI 15189: Medical laboratories - Particular requirements for quality and competence, Geneva, 2007
Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R: Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. Pharm Res 24: 1962-1973, 2007
Glendenning P, Laffer LL, Weber HK, Musk AA, Vasikaran SD: Parathyroid hormone is more stable in EDTA plasma than in serum. Clin Chem 48: 766-767, 2002
Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44: 805-809, 1998
D'Amour P, Brossard JH: Carboxyl-terminal parathyroid hormone fragments: Role in parathyroid hormone physiopathology. Curr Opin Nephrol Hypertens 14: 330-336, 2005
